The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Abramenko Yu.V.

Tver State Medical University, Tver, Russia

Authors:

Abramenko Yu.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(11): 35‑41

Read: 3088 times

Contact the author
Table of contents

To cite this article:

Abramenko YuV. . S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(11):35‑41. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Forty patients, aged from 55 to 74 years, with chronic cerebral ischemia - discirculatory encephalopathy, stages I-II, against the background of arterial hypertension and atherosclerosis were studied. Patients were randomized into 2 equal groups. Patients of the main group received the antioxidant mexidol intramuscular in dose 100 mg during the first 10 days and then perorally in dose 125 mg three times a day during 20 days in the combination with the regular treatment (diroton in dose 5-20 mg daily, cardiomagnyl in dose 75 mg daily). Patients of the control group received regular treatment during 30 days. The efficacy was evaluated at baseline, on the 10th and 30th days after the treatment using clinical scales (the number of complaints, neurological deficit, cognitive and emotional disorders), parameters of cerebral hemodynamics measured with transcranial duplex scanning, laboratory indices of the state of oxidant and antioxidant systems (the content of malonic dialdehyde and superoxide dismutase in the blood plasma as well as the plasma total antioxidant activity). The statistically significant (p<0.05-0.01) reduction in the severity of asthenic and anxiety disorders, the improvement of static-locomotor and cognitive functions as well as of parameters of cerebral hemodynamics due to the decrease in the peripheral vascular resistance and the normalization of venous outflow from the cavity of scull was seen in patients treated with mexidol compared to the baseline and the control group. Mexidol significantly reduced the intensity of lipid peroxidation and increase the total antioxidant activity of the blood. The results obtained in the study allow to consider mexidol as the effective drug in the complex treatment of discirculatory encephalopathy in elderly patients.

Authors:

Abramenko Yu.V.

Tver State Medical University, Tver, Russia

Close metadata

References:

  1. Bleikher V.M., Kruk I.V., Bokov S.N. Metodiki dlya issledovaniya vnimaniya i psikhomotornykh reaktsii. Klinicheskaya patopsikhologiya. M 2002; 57-69.
  2. Vein A.M. i dr. Depressiya v nevrologicheskoi praktike (klinika, diagnostika, lechenie). M: MIA 2002; 155.
  3. Vertkin A.L., Donchinova A.A., Naumov A.V., Skorikova Yu.S. Sistema koordinat dlya vybora neiroprotektivnoi terapii. RMZh 2007; 15: 16: 1211-1216.
  4. Voronina T.A., Smirnov L.D., Goryainova I.I. Mekhanizm deistviya i obosnovanie primeneniya preparata meksidol v nevrologii. M 2002; 14.
  5. Gusev E.I., Skvortsova V.I. Khronicheskaya ishemiya mozga. M: Meditsina 2003; 318.
  6. Damulin I.V., Parfenov V.A., Skoromets A.A., Yakhno N.N. Narusheniya krovoobrashcheniya v golovnom i spinnom mozge. Bolezni nervnoi sistemy: Rukovodstvo dlya vrachei. V 2 t. T. 1. Pod red. N.N. Yakhno, D.R. Shtul'mana. 2-e izd., pererab. i dop. M: Meditsina 2001; 231-302.
  7. Korobeinikova E.N. Modifikatsiya opredeleniya produktov perekisnogo okisleniya lipidov v reaktsii s tiobarbiturovoi kislotoi. Lab delo 1989; 7: 8-9.
  8. Kryzhanovskii G.N. Obshchaya patofiziologiya nervnoi sistemy. M 1997; 352.
  9. Lavrov A.Yu., Yakhno N.N., Buziashvili Yu.I., Shumilina M.V. Kharakteristika arterial'noi i venoznoi tserebral'noi gemodinamiki na raznykh stadiyakh distsirkulyatornoi entsefalopatii. Prilozhenie "Insul't". Zhurn nevrol i psikhiat 2005; 15: 4-12.
  10. Levin O.S. Distsirkulyatornaya entsefalopatiya: sovremennye predstavleniya o mekhanizmakh razvitiya i lechenii. M: Serv'e 2006; 24.
  11. Levin O.S., Yunishchenko N.A. Diagnostika i lechenie kognitivnykh narushenii pri distsirkulyatornoi entsefalopatii. Consilium Medicum 2008; 9: 8: 47-52.
  12. Levin O.S. Diagnostika i lechenie dementsii v klinicheskoi praktike. MEDpress-inform 2010; 256.
  13. Lelyuk V.G., Lelyuk S.E. Ul'trazvukovaya angiologiya. 2-e izd., dopoln. i pererab. M: Real'noe vremya 2003; 336.
  14. Leshchinskii L.D. Obosnovanie i opyt primeneniya ingibitorov perekisnogo okisleniya lipidov (POL) u bol'nykh ishemicheskoi bolezn'yu serdtsa. TOP-meditsina 1998; 4: 9-11.
  15. Medvedeva L.A., Zagorul'ko O.I., Gnezdilov A.V. Neiroprotektivnaya korrektsiya paroksizmal'nykh rasstroistv pri vegetososudistoi distonii. M 2006; 23.
  16. Mit'kov V.V. Klinicheskoe rukovodstvo po ul'trazvukovoi diagnostike. M 1999; 4: 211-212, 274.
  17. Odinak M.M., Voznyuk N.A. Meksidol v lechenii ostroi i khronicheskoi ishemii golovnogo mozga. Vestn praktich nevrol 2003; 7: 21-26.
  18. Rumyantseva S.A., Kravchuk A.A., Silina E.V. Antioksidanty v terapii tserebrovaskulyarnykh zabolevanii. Lechashchii vrach 2006; 5: 42-47.
  19. Semchenko L.N., Drozdova T.V., Zinov'eva M.N. Primenenie preparata meksidol dlya lecheniya bol'nykh s khronicheskoi tserebrovaskulyarnoi nedostatochnost'yu s vestibulokokhlearnymi proyavleniyami. Prilozhenie 1. Byulleten' eksperimental'noi biologii i meditsiny 2006; 75-78.
  20. Smirnova I.N., Fedorova T.N., Tanashyan M.M., Suslina Z.A. Klinicheskaya effektivnost' i antioksidantnaya aktivnost' meksidola pri khronicheskikh tserebrovaskulyarnykh zabolevaniyakh. Atmosfera. Nervnye bolezni 2006; 1: 33-36.
  21. Stakhovskaya L.V., Gudkova V.V. Mesto distsirkulyatornoi entsefalopatii v strukture tserebrovaskulyarnykh zabolevanii. Voprosy diagnostiki i lecheniya. Prilozhenie k zhurnalu Consilium medicum. Nevrologiya 2009; 2: 28-34.
  22. Suslina Z.A., Smirnova I.N., Tanashyan M.M. i dr. Meksidol pri khronicheskikh formakh tserebrovaskulyarnykh zabolevanii. Lechenie nervnykh boleznei 2002; 3: 28-33.
  23. Tupeev I.R., Kryzhanovskii G.N., Nikushkin E.V. i dr. Antioksidantnaya sistema v dinamike kompleksnogo lecheniya bol'nykh epilepsiei traditsionnymi protivosudorozhnymi preparatami i antioksidantom - al'fa-tokoferolom. Byulleten' eksperimental'noi biologii i meditsiny 1993; 10: 362-364.
  24. Fedin A.I. Oksidantnyi stress i primenenie antioksidantov v nevrologii. Atmosfera. Nervnye bolezni 2002; 1: 15-18.
  25. Fedin A.I., Rumyantseva S.A. Intensivnaya terapiya ishemicheskogo insul'ta. M: Med kniga 2004; 284.
  26. Shalashova M.L., Dudaeva N.G., Golovacheva T.V. Primenenie meksidola v kombinirovannoi terapii s traditsionnymi antigipertenzivnymi sredstvami u bol'nykh arterial'noi gipertenziei s priznakami khronicheskoi tserebral'no-sosudistoi nedostatochnosti. Prilozhenie 1. Byulleten' eksperimental'noi biologii i meditsiny 2006; 152-156.
  27. Shanin Yu.N. i dr. Antioksidantnaya terapiya v klinicheskoi praktike. St-Peterburg: Izd-vo ELBI 2003; 121.
  28. Shetekauri S.A. Sovremennye vozmozhnosti antioksidantnoi terapii i opyt lecheniya meksidolom khronicheskoi tserebrovaskulyarnoi nedostatochnosti. Prilozhenie 1. Byulleten' eksperimental'noi biologii i meditsiny 2006; 156-159.
  29. Shumilina M.V. i dr. Disbalans venoznogo tserebral'nogo krovoobrashcheniya v geneze entsefalopatii u bol'nykh s serdechno-sosudistymi zabolevaniyami. Annaly khir 2001; 4: 62-67.
  30. Yakhno N.N., Damulin I.V., Zakharov V.V. i dr. Primenenie tanakana pri nachal'nykh stadiyakh sosudistoi mozgovoi nedostatochnosti: rezul'taty otkrytogo mnogotsentrovogo issledovaniya. Nevrologicheskii zhurn 1998; 3: 6: 18-22.
  31. Yakhno N.N., Damulin I.V., Zakharov V.V. Distsirkulyatornaya entsefalopatiya. M 2000; 32.
  32. Beck A.T. et al. An inventory for measuring depression. Arch Gen Psichiat 1961; 5: 561-571.
  33. Denckla M.B. Revised neurological examination for subtle signs. Psychopharm Bull 1985; 21: 773-789.
  34. Dubois V., Slachevsky A., Litvan I., Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000; 55: 1621-1626.
  35. Folstein M.F., Filstein S.E., McHugh P.R. Mini-Mental State: a practical guide for grading the mental state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
  36. Guy W., Bonato R. CGI - Clinical Global Impressions Manual for the ECDEU Assessment Battery 2 Rev. National Institute of Menthal Health. Ed. Chevy Chase. Maryland 1976; 12: 1-6.
  37. Lipton R. Ischemic Cell Death in Brain Neurons. Physiological Reviews 1999; 79: 1431-1568.
  38. Manno E.M., Atkinson J.L., Fulgham J.R. et al. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Proc 2005; 80: 420-433.
  39. Spilberger S.D. et al. Manual for the State-Trait Anxiety Inventory. Palo Alto 1970; 38.
  40. Tinnetti M.E. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriat Soc 1986; 34: 119-126.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.